-
1 Comment
Healthcare & Medical Investment Corporation is currently in a long term uptrend where the price is trading 14.4% above its 200 day moving average.
From a valuation standpoint, the stock is 119.1% more expensive than other stocks from the Real Estate sector with a price to sales ratio of 10.6.
Healthcare & Medical Investment Corporation's total revenue sank by 0.0% to $1B since the same quarter in the previous year.
Its net income has dropped by 0.0% to $472M since the same quarter in the previous year.
Finally, its free cash flow fell by 17.7% to $632M since the same quarter in the previous year.
Based on the above factors, Healthcare & Medical Investment Corporation gets an overall score of 1/5.
Exchange | TSE |
---|---|
CurrencyCode | JPY |
ISIN | JP3047910009 |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
Dividend Yield | 5.7% |
---|---|
Market Cap | 40B |
Beta | 0.08 |
PE Ratio | 21.73 |
Target Price | None |
HCM was established under the Act on Investment Trusts and Investment Corporations (Act No. 198 of 1951, as amended; hereinafter, the "Investment Trust Act") with Healthcare Asset Management Co., Ltd. (hereinafter, the "Asset Management Company" or "HAM") as the organizer on December 9, 2014. HCM was listed on the Real Estate Investment Trust Securities Market of Tokyo Stock Exchange, Inc. (hereinafter, the "Tokyo Stock Exchange") on March 19, 2015 (securities code: 3455). The total number of investment units issued and outstanding as of the end of the fiscal period ended January 2025 (August 1, 2024 to January 31, 2025) (hereinafter, the "20th fiscal period" or the "current fiscal period") stands at 359,500 units.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3455.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025